Rifampicin and Letermovir as potential repurposed drug candidate for COVID-19 treatment: insights from an in-silico study
Yamini Pathak, Amaresh Mishra, Gourav Choudhir, Anuj Kumar, Vishwas Tripathi
Topics & Concepts
Drug repositioningCytokine stormPharmacologyIn silicoMedicineDrugRepurposingComputational biologyCoronavirus disease 2019 (COVID-19)Intensive care medicineInternal medicineBiologyInfectious disease (medical specialty)BiochemistryGeneDiseaseEcologyComputational Drug Discovery MethodsCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research